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Abstract
Background. Pain is a major concern for individuals
with cancer, particularly older adults who make up
the largest segment of individuals with cancer and
who have some of the most unique pain challenges.
One of the priorities of hospice is to provide a pain-
free death, and while outcomes are better in hospice,
patients still die with poorly controlled pain.
Objective. This article reports on the results of
a Translating Research into Practice intervention
designed to promote the adoption of evidence-
based pain practices for older adults with cancer in
community-based hospices.
Setting. This Institutional Human Subjects Review
Board-approved study was a cluster randomized
controlled trial implemented in 16 Midwestern
hospices.
Methods. Retrospective medical records from
newly admitted patients were used to determine the
intervention effect. Additionally, survey and focus
group data gathered from hospice staff at the
completion of the intervention phase were analyzed.
Results. Improvement on the Cancer Pain Practice
Index, an overall composite outcome measure of
evidence-based practices for the experimental sites,
was not significantly greater than control sites.
Decrease in patient pain severity from baseline to
post-intervention in the experimental group was
greater; however, the result was not statistically sig-
nificant (P = 0.1032).
Conclusions. Findings indicate a number of factors
that may impact implementation of multicomponent
interventions, including unique characteristics and
culture of the setting, the level of involvement with
the change processes, competing priorities and
confounding factors, and complexity of the innova-
tion (practice change). Our results suggest that
future study is needed on specific factors to target
when implementing a community-based hospice
intervention, including determining and measuring
intervention fidelity prospectively.
Key Words. Elderly; Cancer Pain; Pain Assess-
ment; Pain Management; Hospice
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Introduction
Pain is a major concern for individuals with cancer. The
majority of cancer patients are older adults, a population
that presents unique challenges for effective pain
assessment and management, including misconceptions
about pain, evaluating pain in those with cognitive
impairments, increased sensitivity to medication side
effects, multiple comorbidities, polypharmacy issues,
practical barriers to adherence, and reluctance to take
opioid analgesics [1–5].
In the hospice setting, the majority of patients are older
adults, many with advanced cancer. One of the priorities
of hospice is to assure safe and comfortable dying, and
although pain outcomes are better in hospice than non-
hospice settings, there remains considerable variation.
Patients in hospice still die with poorly controlled pain
[6]. Evidence-based practice (EBP) is the use of current
best research evidence in combination with clinical
expertise and patient values in health care decision
making [7]. However, the application of EBP for
pain assessment and management by nurses and phy-
sicians is sporadic at best [8–11]. Despite the
availability of evidence-based (EB) practice guidelines
to improve management of pain in older adults, adoption
and use of recommendations based on best
scientific evidence lags. This gap in recommended pain
practices has been documented in the care of older
adults with cancer pain in community-based hospice
settings [12].
Implementation strategies to promote the use of best
practices by clinicians have been studied, but which
combination of strategies are effective is not known.
Translating Research into Practice (TRIP) research evalu-
ates approaches to facilitate quality health care prac-
tices. This article reports on the results of a TRIP
intervention, which is multifaceted and includes strate-
gies designed to promote adoption of EB pain manage-
ment practices for older adults with cancer in
community-based hospice settings, hereafter referred to
as TRIP-CA. Although a TRIP intervention was success-
ful in improving pain management practices and in
decreasing costs for older adults in an acute care
setting, the effectiveness of a multifaceted TRIP model to
promote the use of EB pain practices in the community-
based hospice setting is unknown [13,14]. Following
implementation of the TRIP-CA intervention, we hypoth-
esized that [1] nurses and physicians at the experimental
(E) hospices would show a greater increase in the adop-
tion of EBP for pain management than those in the
control (C) hospices; and [2] mean pain severity ratings
for older patients with cancer admitted to E hospices
would be lower at two time periods following hospice
admission (P2 = 3–7 days and P3 = 8–14 days) than in
the C group. In addition to data collected to address
these hypotheses, post hoc focus groups and data from
a process evaluation questionnaire completed by
hospice staff were used to further evaluate the TRIP-CA
intervention.
Methods
Study Design and Sample
A cluster randomized controlled trial (RCT) was used to
test the effect of the multifaceted TRIP-CA intervention on
promoting adoption of EBP for pain management in older
adults with cancer receiving community-based hospice
care. Sixteen Midwestern hospices were recruited with a
representative sample of four small (average daily census
[ADC] = 25 or less), eight medium (ADC = 26–100), and
four large organizations (ADC = greater than 100). The
majority (75%) reported an organizational structure with
the hospice as part of a larger organization such as, a
hospital, Department of Health, or health care organiza-
tion. The remaining hospices were independent organiza-
tions. Fifteen of the 16 hospices were not-for-profit
organizations. Inclusion criteria for the hospices were a
minimum of 30 older patients admitted per year and
serving older patients with a cancer diagnosis in a
community-based hospice setting. For the purposes of
this study, community-based hospice was defined as a
setting where patients received hospice care in an envi-
ronment that allowed the patient or their family caregiver
to oversee the implementation of the pain treatment plan
(e.g., personal home or assisted living). Hospices were
first stratified by size and then randomly assigned into the
E or C group.
Demographic data about staff were collected from the 16
participating hospices at two time points: baseline (August/
September 2006) and post-intervention (September/
October 2008). At baseline, the provider sample consisted
of 383 nurses and 16 physicians. At post-intervention, the
total number of nurses increased to 415, while the total
number of physicians was unchanged. Demographic char-
acteristics of providers are presented in Table 1.
EBPs for pain assessment and management implemented
by hospice medical professionals (nurses and physicians)
were the target of the intervention. A sample of medical
records (MRs) of older hospice patients cared for provided
the data source to evaluate provider practices. Inclusion
criteria for MR were patients 65 years or older, with a
cancer diagnosis, newly admitted to hospice, and receiv-
ing hospice services in a community-based setting. An
average of 30 MRs for patients meeting eligibility criteria
were randomly selected from each hospice for the desig-
nated timeframes (baseline: from February 1 to July 30,
2006; post-intervention: from April 1 to September 30,
2008). For hospices that did not have a minimum of 30
eligible MR during the defined period, all eligible records
were selected.
Post hoc qualitative focus groups with hospice profes-
sionals (nurses, physicians, and social workers) were con-
ducted after the intervention phase at each of the eight E
sites to provide feedback on the TRIP-CA intervention and
barriers and facilitators to practice change. The focus
group participants completed a process evaluation ques-
tionnaire described below at the end of the intervention
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phase and prior to the focus group session. Detailed
information on the focus group process and analysis is
available elsewhere [15].
The study was approved by the Institutional Human Sub-
jects Review Board (IRB) at the University of Iowa, as well
as corresponding human subjects review boards at the
participating hospices with access to an internal IRB. The
University of Iowa IRB served as the IRB of record for
those hospices without an IRB.
TRIP-CA Intervention
TRIP-CA was adapted from a model developed by
Rogers’ diffusion of innovation (DoI) framework
[13,16,17]. Figure 1 outlines the components of the mul-
tifaceted intervention. The TRIP-CA intervention follows
the DoI framework that suggests that the components of
the model (the characteristics of the innovation, the
communication process, the social system, and the
users) interact and impact the adoption of the innovation
(e.g., cancer pain EBPs in older adults) and, ultimately,
patient outcomes.
Characteristics of the EBP include the nature and com-
plexity of the practice guidelines and the tools and
resources to prompt and facilitate practice change.
Opinion leaders, change champions, and educational
training and outreach are key elements in the communi-
cation process that promote the use of EBP [17–21]. The
social system, defined as a set of interrelated members
engaged in joint problem solving to accomplish a common
goal, can have a significant influence on adoption of EBPs
[17,22–26] and includes senior leadership support, train-
ing new staff, and modifying policies and procedures.
User engagement through performance gap assessment,
audit and feedback of practices, and adapting EBPs to
the setting are influential as well [27,28].
The TRIP-CA intervention consisted of the engagement
phase, a 5-month period (February to June 2007) pre-
intervention, and the implementation phase, 12-month
period (July 2007 to June 2008). During the engagement
phase, all 16 hospices received copies of the three rel-
evant clinical practice guidelines (CPG) existing at the time
of the study that addressed the innovation for the
TRIP-CA study, EBPs for cancer pain management in
older adults in community-based hospices. The CPGs
provided recommendations for acute pain management
for older adults, pain management for adults with cancer,
and pain management recommendations for patients in
hospice and palliative care settings. These included The
EBP Guideline: Acute Pain Management in Older Adults
[29]; The American Pain Society Guideline for the Man-
agement of Cancer Pain in Adults and Children [30]; and
The National Consensus Project (NCP) Clinical Practice
Guideline for Quality Palliative Care [31].
In addition, the eight E hospices participated in a number
of activities during the engagement phase including: 1)
selection of local opinion leaders (called pain facilitators
[PF]), nurse champions (NC), and physician champions
(PC); 2) participation by PF and champions in a 3-day
train-the-trainer (TTT) program hosted by the grant team,
which provided an overview of project implementation and
EBPs for pain assessment and management for older
Intervention:
• Localization
• Practice Prompts
    --Quick Reference Guides
    --Algorithms
• Educational Aids
Communication 
Process
Users
Nurses and Physicians
               Intervention:
• Performance gap assessment
• Audit and feedback
• Teleconferences
• Promotional materials
• Trialibility
 C
o
m
m
un
ic
at
io
n
Patient Outcomes
• Pain Intensity
• Pain Interference
• Pain Relief
• Quality of Life (QOL)
*APS, Acute Guideline, NCP
Characteristics of the EBPs
                        Intervention:
• Senior Leadership Program
• Modify policies, procedure, standards
• Modify medical record forms
• Senior administrator support
• Orientation of new staff
Community Hospice
Social System
Adoption of EBPs
• Provider Adherence to EBPs
• Patient Adherence              Intervention:
• Pain Facilitator (OL) and
  Change Champion
  --Train-the-Trainer
• Academic Detailing
• Staff Education
• Outreach Consultation
• Email Listserve
Figure 1 TRIP Cancer Pain Intervention.
* APS = Guideline for the Management of Cancer Pain in Adults & Children (American Pain Society)
Acute = Evidence-Based Practice Guideline: Acute Pain Management in Older Adults (Herr et al.)
NCP = Clinical Practice Guidelines for Quality Palliative Care (National Consensus Project)
Modified by M. Titler and K. Herr from M.G. Titler and L.Q. Everett [16].
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adults with cancer in a hospice setting; 3) review of
performance gap assessment data, which included an
on-site review of their hospice specific baseline data on
48 indicators of EBPs identified from the guidelines; 4)
targeted senior leadership engagement, which consisted
of an on-site meeting with the hospice leadership team at
each E site to detail the project, review data, and encour-
age participation in and support of the intervention; and 5)
on-site academic detailing about pain EBPs with the PCs
provided by a physician with expertise in both pain man-
agement and the hospice setting.
At the beginning of the implementation phase, the eight
E hospices received EBP pain resources and aid to
facilitate use of EBP recommendations, including
pocket-sized laminated pain rating scales for all nurses,
copies of quick reference guides, and patient education
handouts related to non-pharmacologic interventions.
During the first 3 months of the implementation phase,
all nurses at the E sites completed an EBP pain assess-
ment and management education program provided via
DVD. On a monthly basis during the implementation
phase, the E sites also received an outreach visit from
the grant expert nurse, who provided support and coun-
seling related to EBP pain issues, as well as issues
related to implementation of the intervention. The expert
nurse also completed a chart audit on the 48 EBP indi-
cators during her monthly visit, which provided data for
bi-monthly audit and feedback to the sites comparing
with baseline practices identified in the engagement
phase. The expert nurse was also available during
monthly site visits and via email to assist the E hospices
as they modified their standards and documentation
forms to ensure that they aligned with EBPs for pain
assessment and management.
Additional activities during the implementation phase
included a monthly teleconference among the local PF,
NC, and grant investigators and staff to discuss the inter-
vention and implementation progress and strategies to
assist in promoting uptake. This activity also supported
networking and sharing successes between the E sites.
The final activity during the implementation phase was an
e-mail LISTSERV (L-Soft International Inc.; Landover, MD,
USA) facilitated by experts in pain management and
hospice from medicine, nursing, social work, and phar-
macy. Any interested staff from the E hospices could
participate in the weekly discussions related to pain
assessment and management, as well as receive feed-
back related to specific pain-related issues that they were
dealing with in their practice.
Study Instruments and Measures
The dependent variables for this study were the adoption
of 11 EB cancer pain practices for older adults in a
community-based hospice setting and mean pain severity
(intensity) of older adults with cancer served by the hos-
pices. The medical record abstraction tool was developed
specifically for grant use based on the comprehensive list
of 48 indicators of EBP for pain management audited
during the intervention and was used to provide data for
calculating the measure of overall adoption of EB cancer
pain practice indicator for older adults and mean pain
severity. Due to the nature of the hospice MR (e.g., vari-
able formats, narrative in nature, and lack of consis-
tent language), data were abstracted by two trained
research assistants (RA), who were nurses with clinical
experience working with older adults in hospice, oncology,
or long-term care settings. Any discrepancies were
reviewed by a third RA to adjudicate entry. The adoption of
EB cancer pain practices was measured by a composite
of key provider practices on the cancer pain practice index
(CPPI) developed by the research team using a modified
Delphi approach with national pain and hospice experts.
The CPPI focuses on 11 key EBP indicators for pain
relevant to older adults with cancer receiving community-
based hospice care and included pharmacological and
non-pharmacological management (Table 3 provides the
complete list of the 11 EBPs included on the CPPI).
To determine a total score on the CPPI, the number of
points received on the applicable items for that particular
patient (maximum of 11, if all items apply) is divided by the
maximum score possible on all applicable items resulting
in the percentage of EBPs the patient received. The higher
the CPPI score, the greater the percentage of EBPs the
patient received. Although ideally all patients would
receive each applicable pain practice 100% of the time,
with input from an expert panel, a target of 75% as
acceptable for success on each indicator was estab-
lished. Inter-rater reliability of the CPPI was established at
93% with intra-rater reliability of 95%. A detailed descrip-
tion of the CPPI development and psychometrics is
reported elsewhere [32].
All hospice executive directors or their delegates com-
pleted an organizational demographic questionnaire at
baseline and post-intervention related to 1) organizational
characteristics; 2) staff characteristics; and 3) pain poli-
cies, procedures, and available pain resources.
Mean pain severity was based on 0–10 numeric rating
scale (NRS) reports of pain severity recorded in the
medical record. Patients’ pain severity levels on a 0- to
10-point scale were defined as none (0), mild (1–4), mod-
erate (5–6), and severe (7–10) [33,34]. Patients who
reported pain at “0” on admission, but who had orders for
pharmacologic or non-pharmacologic therapies, were
included in the group with pain. For patients with only a
verbal descriptor scale (VDS) report of pain, the VDS
scores were converted into numeric scores by calculating
the mean pain severities for each category (mild, moder-
ate, and severe) based on all patient numeric pain severity
scores in the sample. Patients with cognitive impairments
who were not able to self-report pain were not included in
the analysis of pain severity (N = 35), as no objective
measure of pain was in the MR for most patients.
A post hoc process evaluation questionnaire developed
specifically for the grant was used to gather information
about the TRIP-CA intervention from E hospice staff. The
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questionnaire used a five-point Likert scale (1 = not helpful
and 5 = very helpful) to rate all intervention activities
and resources.
Post-intervention focus groups, conducted by a trained
nurse facilitator, were guided by the qualitative interview
guide, a semi-structured interview tool to solicit feedback
from E hospice staff on perceptions of the impact of
the intervention components on the implementation
process in their facility, and barriers and facilitators to EBP
implementation.
Data Analysis
Study aims were analyzed using descriptive statistics and
linear and logistic regression models. All analyses were
performed using SAS 9.2 (SAS Institute Inc.; Cary, North
Carolina, USA). A P value of 0.05 was required for statis-
tical significance.
Demographic characteristics of patients, nurses/
physicians, and hospices were analyzed using descriptive
statistics. Differences in demographic characteristics
between the E and the C groups were assessed using
binomial logistic regression (for variables with two catego-
ries) or multinomial logistic regression (for variables with
more than two categories). In modeling the demographic
characteristics of the hospices, the hospice was treated
as the unit of analysis. When appropriate, the models were
adjusted for overdispersion.
The pain severity of each patient was computed based on
the mean pain severity of all assessments in each of three
periods in their hospice stay: P1 = admission, defined as
the first 48 hours; P2 = days 3–7; and P3 = days 8–14. P
values were obtained from a proportional odds model to
test if the change of the number of patients from baseline
to post-intervention across three categories of pain sever-
ity (mild, moderate, and severe) was significantly different
between the E and the C group.
The key and additional pain practice indicators were
recorded as a 0/1 binary variable (reflecting whether the
patient received the practice). For indicators based on
multiple components, achievement on at least 75% of the
components was required to receive a 1. For indicators
that had only one component but were completed mul-
tiple times over the 2-week period, 100% achievement
was required to receive a 1. For each patient, the CPPI
was calculated as the percent of key pain practice indica-
tors received of those that were applicable to that patient.
The overall CPPI score was summarized by the mean
percentage across patients. In modeling the CPPI, the
overall measure of EBP adoption, the patient was treated
as the unit of analysis. To account for the correlation
between patients within the same hospice, we used gen-
eralized estimating equations (GEE) and assumed an
exchangeable working correlation structure [35].
The main explanatory variable reflecting the intervention
indicates whether the patient’s medical record was part of
the baseline data or post-intervention data, and in the E or
C group. Nine additional explanatory variables were con-
sidered: patient variables age and gender; hospice vari-
ables size and organizational structure; nurse variables
registered nurse (RN) education, RN certification, and RN
case load; and physician variables medical director status
and medical director certification. The variable race was
not used due to an insufficient representation of patients in
some of the categories.
To determine the final model, forward selection was
performed on the initial model featuring the intervention
variable only. Significant explanatory variables, along with
two-way interactions between these variables and the
intervention variable, were included in the final model.
The effect of the TRIP-CA intervention can be summarized
by the difference between improvements on the mean
CPPI from baseline to post-intervention in the E group
compared with the C group. Our goal was to characterize
the intervention effect after controlling for explanatory vari-
ables and accounting for baseline differences. We applied
Poisson generalized linear models (GLMs) with the CPPI
as the dependent variable.
Analyses of other outcomes were also conducted using
the GLM/GEE framework. The normal distribution was
assumed for continuous outcomes, the binomial or mul-
tinomial distribution was assumed for categorical out-
comes, and the Poisson distribution was assumed for
count outcomes.
Results
Characteristics of Providers
Demographic characteristics of providers were compa-
rable for the E and C groups with no significant differences
at baseline and post-intervention. Differences between E
sites, baseline to post-intervention, and C sites, baseline
to post-intervention, were also not significant. Details on
provider demographics are available in Table 1.
Patient Characteristics
The total patient sample from baseline (T1) and post-
intervention period (T2) included 738 older adults (E = 370,
50.1%; C = 368, 49.8%). Samples for both E and C
groups represent independent samples of patients at T1
and T2. Mean age at T1 was 77.6 years (E = 77.0;
C = 78.3) and at T2 was 78.0 years (E = 78.3; C = 77.7).
The sample was generally cognitively intact at admission,
with only 15.3% of the sample reported as having a cog-
nitive impairment (N = 113). For the patients listed as cog-
nitively impaired (CI) at admission, 66.3% were able to
self-report pain using a NRS or VDS. Of the remaining 35
patients with CI and no self-report documented, 14 (40%)
had pain behaviors documented in the admission assess-
ment, but not in a consistent manner using a validated
pain behavior tool. The remaining 21 (60%) patients had
no pain assessment documented at admission. Demo-
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graphic characteristics of the patients in the E and C
groups were similar for both time periods with no signifi-
cant differences noted (Table 2).
Pain Severity
Overall, 40% (N = 295) of patients had a report of pain
greater than 0 at hospice admission. Additionally, 43%
(N = 314) had an order for a scheduled non-opioid or
opioid analgesic and reported pain, so we inferred that
they had pain that was controlled.
Of the 738 patients in the sample, 59.5% had at least one
report of pain greater than zero during the first 14 days of
hospice care. Of the remaining patients, 16.1% had no pain
across all assessments. The final 4.2% of patients had
missing data or no pain assessments documented during
the first 14 days of hospice care. The initial pain severity
score (first pain assessment documented) for patients with
at least one pain score documented (N = 439) ranged from
none to severe, with 35.1% of patients reporting no pain
and 35.8% reporting mild pain. However, the admission
pain severity score for 128 patients was at the moderate
level or greater, with 15% of patients reporting moderate
pain and 14.1% reporting severe pain. The last pain severity
score for patients with two or more pain scores in the first
14 days of hospice care again ranged from no pain to
severe pain. Of the 410 patients in this group, 49.8%
reported no pain on their last report of pain, 26.3% reported
mild pain; 13.7% reported moderate pain, and 10.2%
reported severe pain as their final pain severity rating
documented during the first 2 weeks of hospice care.
Across all hospice sites, pain assessment was docu-
mented an average of 4.2 times per patient during the first
2 weeks of hospice care with no significant difference
noted between E and C sites. The frequency of pain
severity documentation ranged from 0 (4.2%) to 5 times or
more (41.3%). Of the 707 patients with at least one pain
score reported at some point during the 2-week period,
19.6% reported severe pain at least once.
Provider Pain Practices
Table 3 provides a comparison of individual EB pain prac-
tice indicators and the overall CPPI outcome measure
between E and C groups at baseline and post-
intervention. Consistent across both E and C groups at
baseline and post-intervention, only 30–34% of key appli-
cable EB pain practices were received. There were few EB
Table 1 Demographic characteristics of hospice providers at baseline (T1) and post-intervention (T2)
between experimental and control groups
Experimental
P value
Control
P Value
Difference
T1—T2
by E/CT1 T2 T1 T2
Nurses (N = T1: 383; T2: 415) N (%) N (%) 0.47 N (%) N (%) 0.21 0.65
Full time 145 (64.2) 132 (60.8) 106 (67.5) 121 (61.1)
Part time 81 (35.8) 85 (39.2) 51 (32.5) 77 (38.9)
Nurse education 0.86 0.97 0.99
<BSN 104 (46.0) 141 (65.0) 94 (59.9) 145 (73.2)
BSN 108 (47.8) 69 (31.8) 40 (25.5) 29 (14.6)
>BSN 7 (3.1) 4 (1.8) 4 (2.5) 3 (1.5)
Unknown or not reported 7 (3.1) 3 (1.4) 19 (12.1) 21 (10.6)
Nurse certification 0.49 0.36 0.26
No certification 186 (82.3) 173 (79.7) 113 (72.0) 151 (76.3)
Certification in hospice/palliative
care or pain management
40 (17.7) 44 (20.3) 44 (28.0) 47 (23.7)
Nurse case load (full time) 1.00* 1.00* 1.00
10 or less 3 (37.5) 4 (50) 4 (50) 5 (62.5)
11 or more 5 (62.5) 4 (50) 4 (50) 3 (37.5)
Medical director status (N = 16) 0.07* 0.18* N/A†
Full time 2 (25) 2 (25)
Part time 3 (37.5) 5 (62.5) 2 (25) 4 (50)
Volunteer 5 (62.5) 1 (12.5) 6 (75) 2 (25)
Medical director certified (N = 16) 0.61* 1.00* 0.46
No certification 6 (75) 4 (50) 3 (37.5) 3 (37.5)
Certification: hospice/palliative care 2 (25) 4 (50) 5 (62.5) 5 (62.5)
Remark: P values were calculated based on the logistic regression model (binomial/polynomial outcome) with contrast tests.
N/A = not available.
* P values were calculated using the Fisher’s exact test due to some small numbers in the contingency.
† P value was not available due to zero count in one cell from the contrast test.
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pain practices that more than 75% of patients for which
the practice was applicable received. Practices that were
more consistently evident were using a valid pain scale to
assess pain, completing a primary pain assessment of
pain characteristics, and administering appropriate anal-
gesics for level of pain report. Practices that were particu-
larly low were completing a comprehensive pain
assessment, reassessing pain within 24 hours in those
with moderate/severe pain, and monitoring for most
common analgesic-induced side effects.
Impact of Organizational and Provider Characteristics
on Provider Practices Overall
The Poisson GEE analysis examined the impact of orga-
nizational and provider characteristics on the overall CPPI
score for all hospices (Table 4). Across hospices, five vari-
ables were significantly related to CPPI score: patient age,
hospice size, nurse education level, nurse certification,
and nurse case load. Patients between 65 and 74 years of
age had an overall mean CPPI 10% higher than patients
over 85 years of age. Patients from small hospices
(ADC < 25) had an overall mean CPPI score 11% higher
than patients from large hospices (ADC > 100). Patients
from medium hospices (ADC 26–100) had an overall
mean CPPI score 23% lower than patients from large
hospices (ADC > 100). Patients from hospices with 40%
or more of their nurses having at least a BSN had mean
CPPI scores 6% higher than those patients from hospices
with fewer nurses with BSN or higher. Patients from hos-
pices with 20% or more of their nurses with certification in
hospice/palliative care or pain management had CPPI
scores 6% higher than those from hospices with fewer
nurses certified. Finally, patients from hospices with nurse
caseloads greater than 10 had CPPI scores 29% higher
than patients from hospices with lower nurse case loads.
The following variables showed no significant relationship
to the CPPI: patient gender, patient race, organizational
structure (independent agency vs part of a larger organi-
zation), medical director’s employment status (volunteer,
part time paid, or full time paid), and medical director
certification (certification in hospice and palliative care,
pain management, and other). Significant variables were
included in the final GEE modeling to address the research
questions (Table 4).
Hypothesis 1. We hypothesized that following the
implementation of the TRIP-CA intervention, nurses
and physicians at the E hospice sites would show a
greater increase in the adoption of EPB for pain
than those in the C group.
The contrast tests in the final modeling (Table 4) suggest
that while both the E and the C groups showed improve-
ment from baseline to post-intervention on the CPPI, there
was no significant difference in change on the CPPI
between E and C groups in our primary modeling when
controlling for explanatory variables (P = 0.06). Medium-
sized E hospices did show a greater improvement in CPPI
mean score than medium-sized C sites. However, both
small and large C hospices had a greater improvement on
the CPPI score than their E counterparts. Both the E and
the C groups had high and low performing hospices,
based on the change in the mean CPPI score from base-
line to post-intervention. In the E group, 50% of the eight
sites showed improvement on the mean CPPI from base-
line to post-intervention. In the C group, 62% of the
eight sites showed improvement on the mean CPPI from
Table 2 Demographic characteristics of patients at baseline and post-intervention between experimental
and control groups
(N = 738) Baseline (T1) EC P Value Post-Intervention (T2) EC P Value
Gender N (%)* 0.74 0.06
Female 89 (44.1) 83 (42.1) 91 (54.2) 71 (41.5)
Male 113 (55.9) 114 (57.9) 77 (45.8) 100 (58.5)
Age in years M (SD) 77.0 (7.7) 77.3 (7.1) 78.3 (7.3) 77.7 (7.5)
Age by category N (%)† 0.21 0.87
65–74 89 (44.1) 68 (34.5) 60 (35.7) 63 (36.8)
75–84 79 (39.1) 88 (44.7) 71 (42.3) 68 (39.8)
85 or over 34 (16.8) 41 (20.8) 37 (22.0) 40 (23.4)
Ethnicity N (%)† N/A ¶ N/A ¶
White 134 (66.3) 125 (63.5) 141 (83.9) 136 (79.5)
Black 20 (9.9) 0 (0) 12 (7.1) 1 (0.6)
Other‡ 5 (2.5) 2 (1.0) 1 (0.6) 2 (1.2)
Unknown§ 43 (21.3) 70 (35.5) 14 (8.3) 32 (18.7)
* P values were calculated based on the logistic regression model (binomial) with GEE approach, where Hospice Group (E/C) was
the only independent variable.
† Unable to calculate P values due to limited numbers in some groups.
‡ Hispanic, Asian, and individuals with multiple ethnicities.
§ No documentation regarding race in chart.
¶ P value was not available due to zero count in one cell from the contrast test.
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Table 3 Adoption of evidence-based pain practices as measured by the cancer pain practice index
(CPPI) scores pre and post-intervention
Experimental Group Control Group
Baseline Post Baseline Post
E vs C
N %* N %* Change N %* N %* Chg P Value†
Overall CPPI: mean 202 32.5 166 34.1 +1.6 197 30.8 171 34.1 +3.3 §
Comprehensive Admission Assessment
Individual CPPI Indicators
1. Valid pain scale use at admission 202 67.3 168 86.9 +19.6 197 72.1 171 83.0 +10.9 0.16
2. Comprehensive assessment- primary
(pain intensity, pain location, pain
quality, pain duration/pattern, impact of
pain on function)
175 67.0 159 67.9 +0.9 178 67.0 157 76.3 +9.3 0.21
3. Comprehensive assessment—other
(detailed pain history including
description of previous and current pain
episodes and treatment effectiveness;
physical exam—including
musculoskeletal and neurological
assessment; presence or absence of
delirium; things that make pain better;
things that make pain worse; and
presence of anxiety and depression
175 13.1 159 11.5 -1.6 178 16.5 157 16.7 +0.2 0.67
4. Reports of moderate/severe (5) pain
followed by pain severity reassessment
within 24 hours
47 12.2 44 16.7 +4.5 48 8.2 45 15.2 +7 0.62
5. Increases in pain medications for
consecutive reports of pain severity 5 or
greater within 24 hours
19 32.9 19 49.1 +16.2 19 17.5 22 33.3 +15.8 0.81
6a. Patients with admission report of pain as
mild (1–4) with order for nonopioid or
combination of opioid-nonopioid
analgesic within 24 hours of admission
(items 6a and 6b combined on CPPI)
30 73.3 31 90.3 +17 32 81.3 53 88.7 +7.4 0.51
6b. Points with admission report of pain as
moderate (5–6) or < with order for opioid
analgesic within 24 hours of admission
(items 6a and 6b combined on CPPI)
33 90.9 30 96.7 +5.8 26 92.3 23 95.7 +3.4 0.79
7. Points with opioid order with bowel
regimen initiated (includes both laxative
and stool softener)
172 33.7 160 35.0 +1.3 175 30 150 32.0 +2 0.94
8. Points with opioids ordered who were
monitored each day; a focused
assessment is completed for the five
most common analgesic-induced side
effects: 1) respiratory depression, 2)
sedation, 3) nausea and vomiting, 4)
constipation, 5) delirium
172 19.2 160 19.2 0 175 19.4 150 17.3 -2.1 0.71
9. Non-pharmacologic therapies used 182 39 162 50.6 +11.6 182 11 159 37.1 +26.1 0.00
10. Focused assessments that include a
review of the pain management plan
(PMP)
179 59.9 157 49.1 -10.8 177 61.2 157 53.3 -7.9 0.69
11. Pts. with documentation of a written pain
management plan
127 26.2 143 20.8 -5.4 166 39.3 149 28.4 -10.9 0.57
* An individual CPPI score is presented as a % of applicable EBPs a patient received. The higher the % the more EBPs received.
† The P-values were obtained from logistic regression model using contrast experimental post-intervention (EPI)—experimental baseline (EB)—control
post-intervention (CPI)—control baseline (CB), where each indicator (0 or 1) was treated as the response variable and intervention (4 categories: EPI,
EB, CPI, and CB) was the only independent variable.
§ P-value calculated from GEE final model is reported in Table 4.
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baseline to post-intervention. Table 3 provides information
about the overall CPPI outcomes and individual CPPI
indicators for E compared with C groups.
Hypothesis 2. We hypothesized that following the
implementation of the TRIP-CA intervention, mean
pain severity ratings for older patients with cancer
admitted to E hospices would be lower at two time
periods following hospice admission (P2 = 3–7 days
and P3 = 8–14 days) compared with the C group.
Change in pain severity means from baseline to post-
intervention in the E and C groups for patients with at least
one pain score documented show consistent greater
decreases in the E group at P1 (1st 48 hours) (1.95–1.80),
P2 (1.61–1.38), and P3 (1.62–1.43) compared with the C
group in which pain severity increased at P1 (1.54–1.69)
and P3 (1.24–1.58), and decreased at P2 (1.64–1.42). A
linear regression GEE analysis, controlling for hospice-
specific cluster effects, showed decreases in pain severity
from baseline to post-intervention during the second week
of hospice and in the last pain severity rating in those with
two or more pain scores: however, the results were not
statistically significant (see Table 5).
There was a relatively small percentage of patients expe-
riencing moderate to severe pain at baseline making it
difficult to detect a difference post-intervention. The
changes in pain severity were small and not likely to be
clinically significant.
Table 4 Impact of organization and provider characteristics on provider’s practices measured by cancer
pain practice index (CPPI)
Variables/Category
Estimates of
Coefficients
in the Model P Value
CPPI
Comparison*
Exponential
of Estimates
Intervention† <0.0001
Patient Age <0.0001
74 0.0954 <0.0001 1.1001
75–84 0.0231 0.2215 1.0234
85 Reference Reference Reference
Hospice Size <0.0001
small 0.1128 <0.0001 1.1194
medium -0.2563 <0.0001 0.7739
large Reference Reference Reference
Interaction of size and intervention‡ <0.0001
Nurse education level 0.0260
%BSN or above  0.4 0.0583 0.0260 1.0600
%BNS or above < 0.4 Reference Reference Reference
Interaction of nurse education level and intervention‡ <0.0001
Nurse certification <0.0001
%Certification  0.2 0.0628 <0.0001 1.0648
%Certification < 0.2 Reference Reference Reference
Interaction of nurse certification and intervention‡ <0.0001
Nurse case load <0.0001
>10 0.2483 <0.0001 1.2878
10 Reference Reference Reference
Interaction of case load and intervention‡ <0.0001
Contrast
EPI—EB§ 0.0529 0.3752 1.0543
CPI—CB¶ 0.3877 0.0391 1.4736
(EPI—EB)—(CPI—CB)** -0.3348 0.0615 0.7155
* Ratio of the mean CPPI for a particular group relative to the mean CPPI for the reference group.
† The Intervention variable is based on four categories: experimental baseline (EB)—baseline data for the experimental group,
experimental post-intervention (EPI)—post-intervention data for the experimental group, control baseline (CB)—baseline data for the
control group, and control post-intervention (CPI)—post-intervention data for the control group.
‡ Interactions test whether the effect of a variable on the mean CPPI depends on the category of the intervention variable.
§ The contrast (EPI—EB) tests the improvement of the mean CPPI from baseline to post-intervention in the experimental group.
¶ The contrast (CPI—CB) tests the improvement of the mean CPPI from baseline to post-intervention in the control group.
** The contrast (EPI—EB)—(CPI—CB) compares the improvements on the mean CPPI from baseline to post-intervention in the
experimental group and in the control group.
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Post-Intervention Data about the TRIP-CA Intervention
Of the activities and resources listed on the process evalu-
ation questionnaire as part of the TRIP-CA intervention, 16
received a mean score of 4.5 or greater (5 = very helpful).
The top five activities/resources identified by E staff as
being most helpful in implementing EBP for cancer pain in
older adults included: 1) implementing standard pain
assessment tools, 2) involvement of a local PF, 3) the TTT
program, 4) laminated pain tools, and 5) audit and feed-
back. Conversely, the five activities/resources identified as
the least helpful to EBP implementation (scoring less than
3.75) were 1) involvement of PC; 2) implementing motiva-
tional initiatives; 3) marketing/staff incentive—pocket cal-
culator; 4) press releases to use for hospice newsletters,
local papers, etc.; and 5) key elements handout for phy-
sicians. Post-intervention focus groups provided feedback
useful in interpreting study findings with details provided
elsewhere [15].
Discussion
Although the TRIP-CA intervention resulted in significant
improvements on selected practice indicators for the E
group, there was not a significant intervention effect on the
overall provider adoption score, the CPPI. The variations
between hospices suggest there may be location-specific
factors important to the implementation and dissemina-
tion of EBPs and their adoption that were not controllable
through the explanatory variables identified. The process
of adopting a complex practice change with numerous
recommendations is challenging [8–10]. The difficulties in
changing established health care practices have been well
documented in the acute care setting [13,36–41].
However, less literature is available on implementing EBP
in community-based settings, including hospice [8,42,43].
The findings that fewer than 35% of applicable EBPs are
received, and that 24% of patients reported moderate to
severe pain as their last documented pain score, reinforce
the need for continued efforts to address pain challenges
in this setting caring for older adults with cancer pain.
In evaluating the effect of the TRIP-CA intervention, a
number of factors must be considered: the unique char-
acteristics and culture of the hospice setting, the com-
plexity of the EBP topic that is being promoted, and the
competing priorities of the practice sites. The decentral-
ized environment of hospice made it challenging to com-
municate all components of the TRIP-CA intervention
directly to the staff (RNs and physicians) implementing the
EBPs for pain. EBP information and suggestions for imple-
mentation strategies were often provided to the hospice
PF and NC with limited influence over how this information
was shared with other staff. Consequently, there were
considerable variances across hospice settings with other
information and resource sharing, such as expert outreach
advice, additional training, and communication of audit
and feedback data with frontline staff. A knowledge gap
related to the overall understanding of EBP by staff in the
hospice settings was also identified in the post-
intervention focus groups. Future efforts should include
education of local staff on what EBP is, the benefits of
EBP, and its contribution to improved patient care.
Barriers identified during the post-intervention focus
groups may have had a considerable impact on the imple-
mentation process. Some of the confounding factors
identified were not anticipated (e.g., natural disasters
impacting a number of the sites and repeated turnover of
local project leaders). However, developing a plan that
includes strategies for dealing with potential barriers to
implementation may serve as a road map for future
studies. A detailed description of barriers and facilitators
identified in the TRIP-CA study is reported elsewhere
[15].
Another factor that must be considered when reviewing
the impact of the TRIP-CA intervention is the complexity of
the innovation (e.g., practice change). Collectively, the EB
guidelines serving as the foundation for EBP recommen-
dations resulted in 48 indicators of best practice. As part
of tailoring to one’s organization, we did not prescribe
what core practices were to be addressed, but rather
encouraged each hospice to examine their baseline data
and to establish its own priorities for change. While the
audit and feedback activity presented site-specific feed-
back on the 48 indicators of best practice and was rated
as being very helpful, the number and scope of practice
Table 5 Change in pain severity reports during the first 14 days of hospice care between experimental
and control groups from baseline to post-intervention
Item Description
Experimental Control
Total Baseline Post Baseline Post P Value
Mean last pain severity
rating for patients with
2 or more pain scores
n 410 100 98 109 103 0.4145*
Mean 2.30 2.64 2.51 2.72 2.16
SD 2.86 2.81 2.90 1.91 2.99
Mean pain severity at
the 2nd week†
n 296 70 72 80 74 0.1032*
Mean 2.19 2.42 2.12 1.99 2.24
* P-values were calculated based on the linear regression model with the GEE approach.
† For patients who had at least one assessment with non-zero pain intensity.
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recommendations may have impacted the priority areas
chosen by the hospices and the practice changes
observed. The 11-item overall adherence outcome
measure (CPPI) was developed simultaneously with the
intervention implementation and may have been a better
approach for sharing on-going audit and feedback data in
a more focused, concise format [32]. Other recent imple-
mentation research supports better outcomes with simple
practice changes, and the length of time for implementa-
tion of complex practices takes longer than for simple
practices [17,29,44]. For complex innovations, a staging
of practice changes may provide better outcomes.
While the E site staff indicated that having a PF at each site
was instrumental to the implementation process, the
format for selecting these project leaders should be con-
sidered. In the current study, each E site was allowed to
“select/appoint” a nurse PF and the NC/PC for their
hospice based on a set of criteria/characteristics that
included important qualities needed in these roles [45,46].
In the hospice setting, there were often few nurses or
physicians from which to select for these important roles.
It is unknown if individuals chosen were viewed as
“leaders” by their peers or if enough time to complete the
additional duties of the position was provided. Future
research should address these potential limitations.
A challenge for implementation science research is iden-
tifying methods for measuring fidelity to the implementa-
tion intervention [47–49]. Our study did not prospectively
measure the fidelity to each of the TRIP-CA intervention
components, although the variability in hospice outcomes
from the TRIP-CA intervention suggests that this may
provide valuable information about the strategies used to
promote change. Anecdotally, we observed considerable
variance among hospices regarding their use of key activi-
ties and resources provided as part of the intervention. For
example, all E site PF and change champions received
their organization’s performance gap assessment data
prior to the implementation phase of the study and audit
and feedback data every 2 months during the intervention
phase. However, the dissemination of this information to
end users varied. Another area of variance in this study
was seen in the level of participation in the TTT program
offered to the E sites during the study engagement phase.
Each E site was encouraged to send three representa-
tives, specifically its PF, NC, and PC, to the 3-day TTT
program provided by the research team and other expert
consultants. All eight E sites sent at least one representa-
tive, with only two sites sending their complete local lead-
ership team. While participants rated this activity as
helpful, it remains unclear what mechanisms were used to
share the information gained at the TTT program at each
local site.
Another intervention component with significant variation
was the interaction with the expert nurse during outreach
consultation. While all E sites received 10 site visits, the
interaction with hospice staff during those visits differed
based on the requests of the sites. Some E hospices
requested the expert nurse interact with all their nurses
during staff meetings or training sessions, while others
preferred to have only the PF or NC meet with the expert
nurse. Thus, the level of engagement of the outreach
nurse with hospice staff was variable across the E sites.
Additionally, engagement of physicians in the implemen-
tation process was difficult as noted by the ratings of
nurses and other non-physician hospice staff on the
process evaluation questionnaire. Items related to phy-
sician involvement were all rated as least helpful in
implementing the intervention and were also mentioned in
the post-intervention focus groups as barriers to imple-
mentation [15]. The issue of engaging physicians was also
noted in the prior TRIP study conducted in the acute care
setting [13].
Understanding implementation intervention fidelity, the
degree to which an intervention is delivered as designed,
is important in evaluating the effectiveness of an interven-
tion [50,51]. A key challenge with implementation research
is how to promote adoption of EBPs with tailoring to the
individual organization, while taking into account the vari-
ability of how implementation components are enacted at
each E site. This does, however, reflect real-world prac-
tices and needs to be considered in effectiveness studies.
To our knowledge, this is the first clustered RCT to test the
effectiveness of an implementation intervention for pro-
moting adoption of EB pain management practices in
hospice settings. While success of the TRIP-CA interven-
tion in overall provider adoption of best practices was not
demonstrated, the intervention did impact patient pain
severity ratings and selected pain practices, and qualita-
tive feedback provided insights into the usefulness of the
various TRIP-CA intervention components. The study
contributed to knowledge regarding issues that hospices
should consider when implementing a specific practice
change and provided valuable data on what components
of the TRIP-CA intervention were considered helpful by
users in implementing EBP for pain management in the
hospice setting.
Limitations
The sensitivity of the CPPI to detect change in provider
practices was not established a priori, although individual
practice indicators provided similar outcome findings as
the summative score on the CPPI. Further study of the
best approaches to measure provider practices is war-
ranted. The focus of this study was pain in older adults
with cancer in community-based hospice settings and
thus, cannot be generalized to other community-based
settings.
The use of MR data as the source to determine pain
assessment and management practices is a potential limi-
tation of the data collection. However, a number of studies
have used this method effectively [3,13,52]. Other
approaches, including direct observation, videotaped
observation, and audio-taped sessions, were considered,
but each has limitations and is not feasible in a large
implementation study [50]. Due to cost, potential for bias
1014
Herr et al.
in direct observation, and the role of MRs as the regulatory
and legal foundation for provision of care, we determined
that MR abstraction was the best option for this study.
Assuring quality and accurate documentation of provider
practices is an issue that needs attention for research in
hospices and for clinical practice.
Inability to measure or assure consistent engagement with
each of the intervention components impacts understand-
ing of the intervention effect on outcomes. Because imple-
mentation interventions involve multiple users and multiple
strategies in real-world settings, this gap in knowledge is
of particular importance for future study.
Conclusions and Recommendations for
Future Research
The TRIP-CA intervention was not successful in signifi-
cantly changing provider practices across a group of
selected key pain practices for management of cancer
pain in older adults in community hospices. Considering
that patients received less than 35% of the recommended
EBPs that were applicable to their circumstances, there is
need for continued efforts to address pain practice in this
setting of care.
It is clear from this study that differences in practice set-
tings can have a considerable impact on the outcome of
an implementation intervention. The hospice setting offers
contextual and operational factors unique from acute care
that impact approaches to translating EBPs into consis-
tent use. Future research should focus on determining
what factors specific to community-based hospice should
be targeted when implementing an EBP intervention. It is
equally important to consider concurrently measuring
fidelity to the implementation intervention and examining
factors impacting fidelity in the interpretation of study
outcomes.
The conduct of multicomponent practice change interven-
tions is research intensive and may not be a model that is
replicable on a broad scale in community-based settings,
such as hospice. Future research should explore interven-
tion approaches that rely less on research team members
and can be more fully implemented by organizational staff.
Consideration of use of technology to address identified
barriers could have benefit.
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